Pharma Mar | PHM - Cost Of Sales


Pharma Mar reported EUR3.77M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 191.5M 2.29M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Pharma Mar EUR 3.77M 1.47M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025